SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11841377
Source:
http://linkedlifedata.com/resource/pubmed/id/11841377
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003872
,
umls-concept:C0009429
,
umls-concept:C0033860
,
umls-concept:C0205082
,
umls-concept:C0302523
,
umls-concept:C0556895
,
umls-concept:C0700325
,
umls-concept:C0717758
pubmed:issue
1
pubmed:dateCreated
2002-2-13
pubmed:abstractText
The antitumour necrosis factor (TNF) activity of etanercept has been utilized to generate an important and novel treatment for rheumatoid arthritis. TNF has also been implicated in the pathogenesis of psoriasis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11841377-12366452
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0004041
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0007-0963
pubmed:author
pubmed-author:IyerSS
,
pubmed-author:LoweN JNJ
,
pubmed-author:YamauchiPP
pubmed:issnType
Print
pubmed:volume
146
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
118-21
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11841377-Adult
,
pubmed-meshheading:11841377-Anti-Inflammatory Agents, Non-Steroidal
,
pubmed-meshheading:11841377-Antirheumatic Agents
,
pubmed-meshheading:11841377-Arthritis, Psoriatic
,
pubmed-meshheading:11841377-Drug Therapy, Combination
,
pubmed-meshheading:11841377-Female
,
pubmed-meshheading:11841377-Humans
,
pubmed-meshheading:11841377-Immunoglobulin G
,
pubmed-meshheading:11841377-Male
,
pubmed-meshheading:11841377-Middle Aged
,
pubmed-meshheading:11841377-Psoriasis
,
pubmed-meshheading:11841377-Receptors, Tumor Necrosis Factor
,
pubmed-meshheading:11841377-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
pubmed:affiliation
Clinical Research Specialists, Santa Monica, CA, USA.
pubmed:publicationType
Journal Article